Literature DB >> 11441186

A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60.

X Cao1, T C Südhof.   

Abstract

Amyloid-beta precursor protein (APP), a widely expressed cell-surface protein, is cleaved in the transmembrane region by gamma-secretase. gamma-Cleavage of APP produces the extracellular amyloid beta-peptide of Alzheimer's disease and releases an intracellular tail fragment of unknown physiological function. We now demonstrate that the cytoplasmic tail of APP forms a multimeric complex with the nuclear adaptor protein Fe65 and the histone acetyltransferase Tip60. This complex potently stimulates transcription via heterologous Gal4- or LexA-DNA binding domains, suggesting that release of the cytoplasmic tail of APP by gamma-cleavage may function in gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441186     DOI: 10.1126/science.1058783

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  394 in total

1.  The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain.

Authors:  Stefan F Lichtenthaler; Dirk Beher; Heike S Grimm; Rong Wang; Mark S Shearman; Colin L Masters; Konrad Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  From Alzheimer's disease to skin tumors: the catenin connection.

Authors:  D Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

3.  The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus.

Authors:  Y Gao; S W Pimplikar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

4.  A physiologic signaling role for the gamma -secretase-derived intracellular fragment of APP.

Authors:  Malcolm A Leissring; M Paul Murphy; Tonya R Mead; Yama Akbari; Michael C Sugarman; Mehrdad Jannatipour; Brigitte Anliker; Ulrike Müller; Paul Saftig; Bart De Strooper; Michael S Wolfe; Todd E Golde; Frank M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

5.  The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling.

Authors:  Roberta Roncarati; Nenad Sestan; Meir H Scheinfeld; Bridget E Berechid; Peter A Lopez; Olimpia Meucci; Jane C McGlade; Pasko Rakic; Luciano D'Adamio
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

Review 6.  Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.

Authors:  Dennis J Selkoe
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

7.  Signaling through LRP1: Protection from atherosclerosis and beyond.

Authors:  Philippe Boucher; Joachim Herz
Journal:  Biochem Pharmacol       Date:  2010-10-30       Impact factor: 5.858

8.  Mutation analysis of the presenilin 1 N-terminal domain reveals a broad spectrum of gamma-secretase activity toward amyloid precursor protein and other substrates.

Authors:  Ping Gong; Kulandaivelu S Vetrivel; Phuong D Nguyen; Xavier Meckler; Haipeng Cheng; Maria Z Kounnas; Steven L Wagner; Angèle T Parent; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

9.  The multi-copy mouse gene Sycp3-like Y-linked (Sly) encodes an abundant spermatid protein that interacts with a histone acetyltransferase and an acrosomal protein.

Authors:  Louise N Reynard; Julie Cocquet; Paul S Burgoyne
Journal:  Biol Reprod       Date:  2009-01-28       Impact factor: 4.285

10.  Amyloid beta a4 precursor protein-binding family B member 1 (FE65) interactomics revealed synaptic vesicle glycoprotein 2A (SV2A) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) as new binding proteins in the human brain.

Authors:  Fabian M Nensa; Martin H D Neumann; Andreas Schrötter; Andre Przyborski; Thomas Mastalski; Sergej Susdalzew; Christina Looβe; Stefan Helling; Fouzi El Magraoui; Ralf Erdmann; Helmut E Meyer; Julian Uszkoreit; Martin Eisenacher; Jaehong Suh; Suzanne Y Guénette; Nelli Röhner; Donat Kögel; Carsten Theiss; Katrin Marcus; Thorsten Müller
Journal:  Mol Cell Proteomics       Date:  2013-11-27       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.